G01N 2333/96438
Dibasic site splicing serine proteases
Official title: Dibasic site splicing serine proteases, e.g. furin
G01N2333/96438 (Dibasic site splicing serine proteases) appears on 5 US grants and 12 published applications in this corpus.
Search patents in G01N- Granted patents
- 5
- Published applications
- 12
- Assignees
- 10
- Inventors
- 16
- Latest grant
- 9 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 3 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
By publication year.
Recent patents
- Detection device and detection method9 Nov 2021US 11,169,151 B2Kabushiki Kaisha Toshiba
- Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents21 Feb 2017US 9,573,974 B2La Societe de Commercialisation des Produits de la Recherche Appliquee Socpra-Sciences Sante et Humaines S.E.C.
- Test for non-septic hypovolemic shock13 May 2014US 8,722,352 B2Anazyme
- Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents25 Feb 2014US 8,658,591 B2
- Testing a mammal for presence, progression or stage of a shock condition25 Dec 2012US 8,338,127 B2Anazyme
- Compositions and methods for diagnosis of shock13 May 2021US 2021/0139946 A9Anazyme
- Oncogenic alternative splicing switch of pace4 in cancer17 Oct 2019US 2019/0316211 A1Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaine
- Detection device and detection method23 May 2019US 2019/0154687 A1Kabushiki Kaisha Toshiba
- Compositions and methods for diagnosis of shock3 Jan 2019US 2019/0002952 A1Anazyme
- Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents11 Sep 2014US 2014/0256646 A1Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra San
Most cited
By later US patents